The Dow Jones Industrial Average has been on a downward trend for nine consecutive days, marking its longest losing streak since February 1978. This development has sparked concerns among investors, prompting questions about the underlying factors driving this decline and the potential implications for the market.
One of the key drivers of the losses in the Dow has been UnitedHealth, which has been a significant drag on the price-weighted average over the past eight sessions. The insurer’s stock has plummeted by 20% this month, largely due to a broader sell-off in pharmacy benefit managers following President-elect Donald Trump’s pledge to tackle drug industry middlemen. Additionally, UnitedHealth is grappling with internal challenges, including the tragic shooting of Brian Thompson, the CEO of its insurance unit.
Furthermore, there is a noticeable rotation among investors selling off cyclical stocks in the Dow that initially surged after Trump’s election in November. Companies like Sherwin-Williams, Caterpillar, and Goldman Sachs, which typically perform well in a booming economy, have all seen declines of at least 5% in December. These stocks had a strong showing in November as they were seen as beneficiaries of Trump’s pro-economy policies and deregulatory agenda.
The Dow, known for its representation of blue-chip consumer discretionary and industrial names, is often viewed as a barometer for overall economic conditions. The recent sell-off coincided with renewed concerns about a weakening economy following a slight increase in jobless claims data released last week. Despite these challenges, investors remain optimistic about the economic outlook for 2025 and do not anticipate a repeat of the stagflationary period experienced in the late 1970s.
While the historic losing streak in the Dow has raised some eyebrows, many experts believe that it is not a cause for major alarm. The broader market, as evidenced by the S&P 500 hitting a new high and the Nasdaq Composite reaching a record, continues to perform well. Although the length of the Dow’s sell-off is concerning, the magnitude is relatively modest, with the average only down 3.5% from its recent peak.
It is worth noting that the Dow’s price-weighted methodology, established in the late 19th century, may not accurately reflect the current market landscape due to its lack of diversification and concentration in just 30 stocks. As Mitchell Goldberg, president of ClientFirst Strategies, pointed out, the Dow’s losing streak is more reflective of investors’ focus on tech stocks rather than industrial America.
Looking ahead, many traders believe that the recent downturn in the Dow is temporary and expect a rebound, especially following this week’s Federal Reserve decision. Larry Tentarelli, founder and chief technical strategist of the Blue Chip Daily Trend Report, anticipates buyers to step in and drive the index higher to close out 2024. Despite the current challenges, there is a sense of optimism that the market will bounce back.
In conclusion, while the Dow’s extended losing streak may raise concerns, it is important to consider the broader market context and remain vigilant in monitoring developments. With a potential rebound on the horizon, investors should stay informed and prepared for any market fluctuations.
